Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Delivered to your door

Biological barriers that limit delivery of imaging and therapeutic agents to the tumour pose a technological challenge. One of those barriers, the vascular endothelium, uses vesicles called caveolae to transport proteins across the cell. Annexin A1 (AnnA1) was enriched in the caveolae at the blood–tumour interface of both human and mouse tumours, so the authors generated a fluorescent-conjugated AnnA1 antibody. When injected intravenously in a mouse model of breast cancer, the antibody rapidly crossed the blood vessels and was taken up by tumours, where it remained for over one hour.


  1. 1

    Oh, P. et al. In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors. Nature Med. 20, 1062–1068 (2014)

    CAS  Article  PubMed  Google Scholar 

Download references


Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Villanueva, M. Delivered to your door. Nat Rev Cancer 14, 647 (2014).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing